IL4 and experimental autoimmune encephalomyelitis: In the case of experimental autoimmune encephalomyelitis (EAE), interleukin-4 (IL-4)-induced type 2 immunity suppresses type 1 driven inflammation, thereby ameliorating EAE [25].